Table 3.
Adverse drug events (ADEs) categorised as Class 2 (in ORe descending order)
| (a) Male cases | ||||||
|---|---|---|---|---|---|---|
| No. | ADEs | ORe | (95% CI) | ORp | (95% CI) | Female class |
| 1 | Urinary retention | 3.34 | (2.93–3.82) | 0.79 | (0.69–0.91) | 1 |
| 2 | Fall | 2.29 | (1.93–2.73) | 1.04 | (0.87–1.25) | 2 |
| 3 | Cardiac failure | 2.17 | (1.94–2.43) | 1.07 | (0.95–1.20) | 1 |
| 4 | Osteonecrosis of jaw | 2.14 | (1.83–2.52) | 0.60 | (0.50–0.73) | 2 |
| 5 | Gastrointestinal haemorrhage | 2.14 | (1.89–2.43) | 0.77 | (0.67–0.89) | 2 |
| 6 | Pneumonia aspiration | 2.14 | (1.81–2.52) | 1.14 | (0.96–1.35) | 1 |
| 7 | Melaena | 2.08 | (1.78–2.43) | 0.91 | (0.77–1.07) | 2 |
| 8 | Cerebral haemorrhage | 1.88 | (1.70–2.07) | 0.89 | (0.80–0.99) | 2 |
| 9 | Pleural effusion | 1.81 | (1.54–2.12) | 1.00 | (0.84–1.18) | 2 |
| 10 | Cerebral infarction | 1.79 | (1.62–1.97) | 0.73 | (0.65–0.82) | 2 |
| 11 | Delirium | 1.70 | (1.49–1.94) | 1.01 | (0.87–1.16) | 2 |
| 12 | Decreased appetite | 1.55 | (1.40–1.72) | 1.07 | (0.96–1.20) | 1 |
| 13 | Platelet count decreased | 1.46 | (1.37–1.56) | 0.97 | (0.90–1.04) | 2 |
| 14 | Depressed level of consciousness | 1.40 | (1.21–1.63) | 1.06 | (0.90–1.24) | 2 |
| 15 | Pneumonia | 1.40 | (1.30–1.51) | 1.02 | (0.94–1.11) | 1 |
| 16 | Lymphoproliferative disorder | 1.40 | (1.16–1.68) | 0.11 | (0.06–0.16) | 2 |
| 17 | Death | 1.26 | (1.10–1.43) | 0.62 | (0.53–0.73) | 2 |
| 18 | Hypertension | 1.25 | (1.05–1.50) | 0.69 | (0.56–0.85) | 4 |
| 19 | Renal impairment | 1.17 | (1.08–1.26) | 1.02 | (0.94–1.11) | 1 |
| (b) Female cases | ||||||
|---|---|---|---|---|---|---|
| No. | ADEs | ORe | (95% CI) | ORp | (95% CI) | Male class |
| 1 | Gastrointestinal haemorrhage | 3.69 | (3.15–4.33) | 1.05 | (0.90–1.22) | 2 |
| 2 | Melaena | 3.22 | (2.69–3.86) | 0.93 | (0.77–1.11) | 2 |
| 3 | Fall | 3.05 | (2.63–3.54) | 0.88 | (0.75–1.03) | 2 |
| 4 | Delirium | 2.89 | (2.47–3.38) | 1.11 | (0.94–1.29) | 2 |
| 5 | Cerebral haemorrhage | 2.61 | (2.31–2.97) | 0.83 | (0.72–0.95) | 2 |
| 6 | Blood creatinine increased | 2.16 | (1.71–2.73) | 1.15 | (0.90–1.47) | 1 |
| 7 | Osteonecrosis of jaw | 2.16 | (1.95–2.39) | 0.71 | (0.63–0.80) | 2 |
| 8 | Death | 1.99 | (1.69–2.34) | 0.67 | (0.55–0.81) | 2 |
| 9 | Cerebral infarction | 1.91 | (1.71–2.13) | 0.63 | (0.55–0.72) | 2 |
| 10 | Haemoglobin decreased | 1.46 | (1.24–1.72) | 0.88 | (0.73–1.07) | 4 |
| 11 | Lymphoproliferative disorder | 1.42 | (1.26–1.60) | 0.10 | (0.07–0.13) | 2 |
| 12 | Infection | 1.26 | (1.04–1.54) | 0.50 | (0.38–0.64) | 4 |
| 13 | Platelet count decreased | 1.23 | (1.15–1.32) | 0.97 | (0.90–1.06) | 2 |
| 14 | Lung disorder | 1.21 | (1.01–1.45) | 1.06 | (0.87–1.30) | 1 |
| 15 | Depressed level of consciousness | 1.21 | (1.07–1.37) | 1.05 | (0.91–1.20) | 2 |
| 16 | Pleural effusion | 1.20 | (1.02–1.43) | 1.12 | (0.93–1.35) | 2 |
| 17 | Shock | 1.20 | (1.09–1.32) | 0.89 | (0.80–1.00) | 4 |
| 18 | Dizziness | 1.20 | (1.06–1.35) | 0.94 | (0.82–1.07) | 1 |
| 19 | Stomatitis | 1.19 | (1.02–1.38) | 1.01 | (0.85–1.19) | 4 |
Underlined ADEs are categorised in a separate Class in the other sex
ORe adjusted odds ratio with elderly as a factor for the occurrence of ADEs, ORp adjusted odds ratio with polypharmacy as a factor for the occurrence of ADEs, 95% CI 95% confidence interval of ORe and ORp, Female Class class in which ADEs common in females are categorised, Male Class class in which ADEs common in males are categorised